Peroxisome Proliferator-activated Receptor Alpha Activates Transcription of the Brown Fat Uncoupling Protein-1 Gene. A Link Between Regulation of the Thermogenic and Lipid Oxidation Pathways in the Brown Fat Cell
Overview
Affiliations
High expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) differentiates brown fat from white, and is related to its high capacity of lipid oxidation. We analyzed the effects of PPARalpha activation on expression of the brown fat-specific uncoupling protein-1 (ucp-1) gene. Activators of PPARalpha increased UCP-1 mRNA levels severalfold both in primary brown adipocytes and in brown fat in vivo. Transient transfection assays indicated that the (-4551)UCP1-CAT construct, containing the 5'-regulatory region of the rat ucp-1 gene, was activated by PPARalpha co-transfection in a dose-dependent manner and this activation was potentiated by Wy 14,643 and retinoid X receptor alpha. The coactivators CBP and PPARgamma-coactivator-1 (PGC-1), which is highly expressed in brown fat, also enhanced the PPARalpha-dependent regulation of the ucp-1 gene. Deletion and point-mutation mapping analysis indicated that the PPARalpha-responsive element was located in the upstream enhancer region of the ucp-1 gene. This -2485/-2458 element bound PPARalpha and PPARgamma from brown fat nuclei. Moreover, this element behaved as a promiscuous responsive site to either PPARalpha or PPARgamma activation, and we propose that it mediates ucp-1 gene up-regulation associated with adipogenic differentiation (via PPARgamma) or in coordination with gene expression for the fatty acid oxidation machinery required for active thermogenesis (via PPARalpha).
Sagliocchi S, Schiano E, Acampora L, Iannuzzo F, Cicatiello A, Miro C Foods. 2025; 14(1.
PMID: 39796338 PMC: 11720057. DOI: 10.3390/foods14010048.
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives.
Morciano C, Gugliandolo S, Capece U, Giuseppe G, Mezza T, Ciccarelli G Cardiovasc Diabetol. 2024; 23(1):449.
PMID: 39702365 PMC: 11660748. DOI: 10.1186/s12933-024-02539-x.
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.
Hayes C, Gallucci G, Boyer J, Assis D, Ghonem N Hepatol Commun. 2024; 9(1).
PMID: 39699308 PMC: 11661771. DOI: 10.1097/HC9.0000000000000612.
Hwang J, Okada J, Liu L, Pessin J, Schwartz G, Jo Y PLoS Biol. 2024; 22(10):e3002865.
PMID: 39436946 PMC: 11530026. DOI: 10.1371/journal.pbio.3002865.
Zhai X, Dang L, Wang S, Sun C Int J Mol Sci. 2024; 25(19).
PMID: 39408844 PMC: 11476608. DOI: 10.3390/ijms251910514.